Clinical Trial Update: Study of Pomalidomide in Persons With Myeloproliferative-Neoplasm-Associated Myelofibrosis and RBC-Transfusion-Dependence [Phase 3]

View source ↗

Summary

Phase 3 trial of pomalidomide in myeloproliferative neoplasm-associated myelofibrosis and RBC-transfusion-dependence completed in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis
• Myeloproliferative Neoplasm-associated Myelofibrosis

Drugs mentioned

• Pomalidomide (Pomalidomide)

Snippet

Sponsor: Celgene | Conditions: Primary Myelofibrosis, MPN-associated Myelofibrosis | Phase 3 | Status: COMPLETED | Results posted: 2014-03-14